PCH
BCYC

Polar Capital Holdings’s Bicycle Therapeutics BCYC Stock Holding History

Polar Capital Holdings’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,002,780
Closed -$22.7M – 300
2024
Q3 		$22.7M Sell
1,002,780
-1,755
-0.2% -$40.5K 0.11% 134
2024
Q2 		$20.3M Hold
1,004,535
– – 0.12% 129
2024
Q1 		$25M Hold
1,004,535
– – 0.13% 133
2023
Q4 		$18.2M Sell
1,004,535
-6,965
-0.7% -$115K 0.11% 144
2023
Q3 		$20.3M Buy
1,011,500
+252,000
+33% +$5.76M 0.15% 140
2023
Q2 		$19.4M Sell
759,500
-250,000
-25% -$5.81M 0.1% 155
2023
Q1 		$21.5M Buy
1,009,500
+259,500
+35% +$6.51M 0.14% 135
2022
Q4 		$22.2M Buy
+750,000
New +$20.1M 0.18% 136

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Polar Capital Holdings's BCYC Position: Q4 2024 in Review

Polar Capital Holdings sold out of Bicycle Therapeutics (BCYC) in Q4 2024, closing a stake of 1,002,780 shares — an estimated $22.7M sold.

Polar Capital Holdings first reported a position in BCYC in Q4 2022 and held it in 8 quarters. The position peaked at $25M in Q1 2024. 97 funds tracked by Wall St. Rank hold BCYC as of Q4 2024.

  • Polar Capital Holdings reported no remaining Bicycle Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Polar Capital Holdings sold 1,002,780 Bicycle Therapeutics shares in Q4 2024, an estimated $22.7M.
  • Polar Capital Holdings first reported a position in Bicycle Therapeutics in Q4 2022 and held it in 8 quarters.
  • Polar Capital Holdings's Bicycle Therapeutics position peaked at $25M in Q1 2024.
  • 97 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q4 2024.

Based on Polar Capital Holdings's 13F filing for Q4 2024, filed 14 Feb 2025.